OPKO Health, Inc. (OPK)

NASDAQ: OPK · IEX Real-Time Price · USD
2.45
+0.17 (7.46%)
At close: Aug 8, 2022 4:00 PM
2.44
-0.01 (-0.41%)
Pre-market: Aug 9, 2022 7:03 AM EDT
7.46%
Market Cap 1.89B
Revenue (ttm) 1.43B
Net Income (ttm) -202.12M
Shares Out 771.96M
EPS (ttm) -0.18
PE Ratio n/a
Forward PE 64.52
Dividend n/a
Ex-Dividend Date n/a
Volume 6,044,078
Open 2.35
Previous Close 2.28
Day's Range 2.30 - 2.46
52-Week Range 2.15 - 5.25
Beta 1.76
Analysts Buy
Price Target 6.63 (+170.6%)
Earnings Date Aug 4, 2022

About OPK

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers ... [Read more...]

Industry Biotechnology
IPO Date Nov 2, 1995
CEO Phillip Frost
Employees 5,767
Stock Exchange NASDAQ
Ticker Symbol OPK
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for OPK stock is "Buy." The 12-month stock price forecast is 6.63, which is an increase of 170.61% from the latest price.

Price Target
$6.63
(170.61% upside)
Analyst Consensus: Buy
Stock Forecasts

News

OPKO Health (OPK) Reports Q2 Loss, Lags Revenue Estimates

OPKO Health (OPK) delivered earnings and revenue surprises of -100% and 3.02%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

OPKO Health to Report Second Quarter 2022 Financial Results on August 4, 2022

MIAMI, July 25, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2022 after the close of the U.S. fina...

Here's Why You Should Hold on to OPKO Health (OPK) Stock For Now

Investors continue to be optimistic about OPKO Health (OPK) owing to its potential in Rayaldee and a few strategic agreements.

Penny Stocks, Market Trends in July 2022

Are these market trends part of your penny stocks trading strategy? The post Penny Stocks, Market Trends in July 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols: JAGXOTLY

OPKO Health And 2 More Stocks Under $3 Insiders Are Aggressively Buying

The Dow Jones surged by more than 800 points on Friday. Investors, meanwhile, focused on some notable insider trades.

9 Stock Picks With Important Insider Trading Signals to Buy Now

Bullish insider trading transactions are intriguing for formulating stock picks, particularly during a corrective period in the markets. The post 9 Stock Picks With Important Insider Trading Signals to ...

Other symbols: APLDAPPNCSPISIXVFCVOXX

OPKO Health (OPK) Post In-Line Q1 Earnings, Revenues Top

OPKO Health's (OPK) first-quarter results benefit from continued strength in its Pharmaceuticals segment.

Why Opko Health Stock Is Jumping Today

The company topped Q1 revenue estimates and announced a key new acquisition.

OPKO Health (OPK) Reports Q1 Loss, Tops Revenue Estimates

OPKO Health (OPK) delivered earnings and revenue surprises of 0% and 6.28%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

OPKO Health Acquires ModeX Therapeutics, Gains Proprietary Immunotherapy Technology with a Focus on Oncology and Infe...

Transaction to be discussed during OPKO's first quarter 2022 conference call today at 4:30 p.m. ET

11 Stocks Moving Towards A VWAP Breakout: Tellurian, SM Energy, Freshworks And More

Volume-weighted average price or VWAP is the ratio of total volume traded divided by the total volume traded for a chosen time frame. VWAP is an important indicator for intraday trading as it graphicall...

Reasons to Retain OPKO Health (OPK) Stock in Your Portfolio

Investors continue to be optimistic about OPKO Health (OPK) owing to its potential in Rayaldee and regulatory approvals.

GeneDx Announces Discovery of 200 New and Expanded Genetic Conditions

New research underscores the value of sharing genomic information to advance gene matching for diagnosis and discovery GAITHERSBURG, Md., March 16, 2022 /PRNewswire/ -- GeneDx, Inc., a leader in genomic...

Saol Therapeutics and GeneDx, Inc. Collaborate to Detect Patients with Rare Mitochondrial Disease

ROSWELL, Ga., March 1, 2022 /PRNewswire/ -- Saol Therapeutics, a company researching new treatments for rare diseases, is pleased to announce a collaboration with GeneDx, Inc. a leader in genomic analys...

OPKO Health's (OPK) Q4 Earnings Miss Estimates, Revenues Top

OPKO Health's (OPK) fourth-quarter results benefit from continued strength in its Pharmaceuticals segment.

Why Opko Health Stock Dipped on Friday

A bottom-line earnings miss adds to a general bearishness on coronavirus stocks.

OPKO Health (OPK) Reports Q4 Loss, Tops Revenue Estimates

OPKO Health (OPK) delivered earnings and revenue surprises of -266.67% and 19.93%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

OPKO Health Reports 2021 Fourth Quarter Business Highlights and Financial Results

Conference call begins at 4:30 p.m. Eastern time today Conference call begins at 4:30 p.m. Eastern time today

OPKO Health (OPK) Gains As Market Dips: What You Should Know

In the latest trading session, OPKO Health (OPK) closed at $3.15, marking a +0.32% move from the previous day.

7 Insider Stocks to Buy as Execs Snap Them Up

With equity prices soaring to record levels, many execs have cashed out. Here are the insider stocks where execs are cashing in.

OPKO Health to Report Fourth Quarter 2021 Financial Results on February 24, 2022

MIAMI, Feb. 17, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended December 31, 2021 after the close of the U.S. financia...

OPKO's (OPK) NGENLA to Offer GHD Treatment in European Union

OPKO's (OPK) marketing authorization for NGENLA in the European Union stands to benefit children and adolescents affected by growth hormone deficiency.

Pfizer and OPKO's Once-Weekly NGENLA™ (somatrogon) Injection Receives Marketing Authorization in European Union for T...

NEW YORK & MIAMI--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and OPKO Health, Inc. (NASDAQ: OPK) announced today that the European Commission has granted marketing authorization for the next-generation lo...

Other symbols: PFE

Analysts Estimate OPKO Health (OPK) to Report a Decline in Earnings: What to Look Out for

OPKO Health (OPK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 Penny Stocks To Buy For Under $5 Outperforming FB Stock In 2022

4 penny stocks outperforming Facebook Meta stock today The post 4 Penny Stocks To Buy For Under $5 Outperforming FB Stock In 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | Pen...

Other symbols: APMGTENGL